Secondary |
Pain |
16.9% |
Nausea |
9.6% |
Arthritis |
8.9% |
Thrombosis Prophylaxis |
7.1% |
Hypertension |
6.8% |
Pyrexia |
6.6% |
Fluid Replacement |
4.6% |
Mineral Supplementation |
4.6% |
Diabetes Mellitus |
3.9% |
Infection |
3.7% |
Restlessness |
3.7% |
Acute Myeloid Leukaemia |
3.0% |
Oral Candidiasis |
3.0% |
Sepsis |
3.0% |
Constipation |
2.5% |
Drug Use For Unknown Indication |
2.5% |
Gastrointestinal Disorder Therapy |
2.5% |
Pruritus |
2.5% |
Vomiting |
2.5% |
Anxiety |
2.3% |
|
Toxic Epidermal Necrolysis |
40.7% |
Stevens-johnson Syndrome |
9.3% |
Bladder Tamponade |
5.6% |
Paraplegia |
5.6% |
Vomiting |
5.6% |
Platelet Disorder |
3.7% |
Pyrexia |
3.7% |
Weight Decreased |
3.7% |
Abdominal Pain |
1.9% |
Agranulocytosis |
1.9% |
Depression |
1.9% |
Hyperuricaemia |
1.9% |
Liver Disorder |
1.9% |
Myocardial Infarction |
1.9% |
Rash |
1.9% |
Rash Generalised |
1.9% |
Serotonin Syndrome |
1.9% |
Suicide Attempt |
1.9% |
Syncope |
1.9% |
Thrombotic Microangiopathy |
1.9% |
|
Concomitant |
Drug Use For Unknown Indication |
27.2% |
Product Used For Unknown Indication |
13.6% |
Diffuse Large B-cell Lymphoma |
12.2% |
Prophylaxis |
8.6% |
Nausea |
5.4% |
Pain |
4.8% |
Non-small Cell Lung Cancer |
3.8% |
Vomiting |
3.1% |
Hypertension |
2.8% |
Pyrexia |
2.3% |
Breast Cancer |
2.2% |
Colorectal Cancer Metastatic |
2.1% |
Depression |
1.9% |
Thrombosis Prophylaxis |
1.8% |
Breast Cancer Metastatic |
1.7% |
Constipation |
1.5% |
Musculoskeletal Pain |
1.5% |
Diabetes Mellitus |
1.2% |
Abdominal Pain |
1.2% |
General Physical Health Deterioration |
1.2% |
|
Vomiting |
11.5% |
Syncope |
7.9% |
Febrile Neutropenia |
6.5% |
Pyrexia |
6.5% |
Renal Failure Acute |
6.5% |
Weight Decreased |
6.5% |
Urinary Tract Infection |
5.0% |
Electrocardiogram Qt Prolonged |
4.3% |
General Physical Health Deterioration |
4.3% |
Lung Infiltration |
4.3% |
Pelvic Venous Thrombosis |
4.3% |
Rectal Ulcer |
4.3% |
Thrombocytopenia |
4.3% |
Myalgia |
3.6% |
Neutropenia |
3.6% |
Pneumonia |
3.6% |
Sepsis |
3.6% |
Stevens-johnson Syndrome |
3.6% |
Blood Sodium Decreased |
2.9% |
Cerebrovascular Accident |
2.9% |
|
Interacting |
Depression |
80.0% |
Essential Hypertension |
20.0% |
|
Vertigo |
40.0% |
Fatigue |
20.0% |
Tachycardia |
20.0% |
Vomiting |
20.0% |
|